This esteemed international award celebrates nurses who demonstrate extraordinary clinical skills and provide compassionate, ...

III/IV resectable melanoma remained event-free at four years from the start of neoadjuvant systemic treatment.

Researchers analyzed SOGI data collection practices to determine the factors associated with its prevalence across cancer centers by type and geographic area.

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with ...

Two East Bay women are bringing comfort and confidence to women who've lost hair due to cancer treatment and alopecia.

Establishing routine early on helps proactively manage adverse effects associated with CDK4/6 inhibitors, says Kimberly ...